(Q46082183)

19 December 2017

title

Estimation of creatinine clearance in morbidly obese patients (English)

1 reference

19 December 2017

0 references

0 references

2

Amy Barton Pai

1 reference

19 December 2017

author name string

Jasmina A Demirovic

series ordinal

1

1 reference

19 December 2017

Manjunath P Pai

series ordinal

3

1 reference

19 December 2017

publication date

1 April 2009

1 reference

19 December 2017

American Journal of Health-System Pharmacy

published in

1 reference

19 December 2017

volume

66

1 reference

19 December 2017

issue

7

1 reference

19 December 2017

page(s)

642-648

1 reference

19 December 2017

Prevalence of overweight and obesity in the United States, 1999-2004

cites work

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080200

Obesity, diabetes, and chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080200

Glomerular hemodynamics in severe obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080200

Estimating glomerular filtration rate with a modification of diet in renal disease equation: implications for pharmacy

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080200

Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080200

Predictive performance of ten equations for estimating creatinine clearance in cardiac patients. Iohexol Cooperative Study Group.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080200

What is the best size descriptor to use for pharmacokinetic studies in the obese?

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080200

Prediction of creatinine clearance from serum creatinine

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080200

The origin of the "ideal" body weight equations

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080200

Dosing in obesity: a simple solution to a big problem.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080200

Quantification of lean bodyweight.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080200

Bioelectrical impedance analysis in body composition measurement: National Institutes of Health Technology Assessment Conference Statement

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080200

Effect of obesity on bioelectrical impedance

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080200

A standard weight descriptor for dose adjustment in the obese patient

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080200

Lean body mass normalizes the effect of obesity on renal function.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080200

The obesity epidemic in the United States--gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080200

31 March 2020

Identifiers

DOI

10.2146/AJHP080200

1 reference

19 December 2017

PubMed ID

19299371

1 reference

19 December 2017